Maxacalcitol IV injection syringe for dialysis 2.5μg “Fuso”, manufactured by Fuso Pharmaceutical Industry, contains Maxacalcitol. This injectable vitamin D3 analog is used for the treatment of secondary hyperparathyroidism in patients undergoing hemodialysis. It has a YJ code of 3112401G1037 and a standard of 2.5 μg 1 mL 1 cylinder.
Maxacalcitol IV injection syringe for dialysis 2.5μg “Fuso”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →